Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 428,394 shares at $25.95 ($11.6M) on 2023-01-19, disclosed to the SEC on 2023-01-23.
Open-market sale of $11.6M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.95 | 4,037 | $105K | 0.9% |
| 2 | $25.95 | 4,037 | $105K | 0.9% |
| 3 | $26.59 | 65,802 | $1.7M | 15.1% |
| 4 | $26.59 | 65,802 | $1.7M | 15.1% |
| 5 | $26.86 | 21,585 | $580K | 5.0% |
| 6 | $26.86 | 21,585 |
| $580K |
| 5.0% |
| 7 | $27.51 | 122,773 | $3.4M | 29.1% |
| 8 | $27.51 | 122,773 | $3.4M | 29.1% |
| Total | $27.13 avg | 428,394 | $11.6M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |